Individualizing Automated Closed Loop Glucose Control Through Pharmacokinetic Profiling in an Insulin-Only Bionic Pancreas
Not yet recruiting
Phase of Trial: Phase I
Latest Information Update: 09 Jan 2019
At a glance
- Drugs Insulin aspart (Primary) ; Insulin lispro (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics
- 03 Jan 2019 According to an Adocia media release, investigators at the Massachusetts General Hospital Diabetes Research Center have designed and will perform this study, which is funded by the Leona M. and Harry B. Helmlsey Charitable Trust.
- 02 Jan 2019 Planned End Date changed from 1 Dec 2019 to 1 Dec 2020.
- 02 Jan 2019 Planned initiation date changed from 1 Dec 2018 to 1 Feb 2019.